Japan Introduces Universal Artificial Blood That Could Save Lives

AHMEDABAD, India - July 13, 2025 - PRLog -- Japan has once more established itself at the forefront of medical advancements with the launch of universal artificial blood—a groundbreaking technology that has the potential to transform emergency medical care and blood transfusion methods globally.

What Is Artificial Blood?

Artificial blood, also known as a blood substitute, is a substance designed to mimic the function of red blood cells, primarily their ability to transport oxygen and carbon dioxide throughout the body.

Unlike donor blood, artificial blood doesn't require exact blood-type matching, doesn't carry the risk of infectious diseases, and has a much longer shelf life.

There have been several attempts in the past to develop synthetic blood, but many were either unsafe, ineffective, or failed clinical trials. Japan's latest innovation appears to have overcome many of these hurdles.

The Japanese Breakthrough: Universal Artificial Blood

Researchers in Japan have developed a universal artificial blood that can be transfused into patients of any blood type—A, B, AB, or O. This synthetic substitute contains both red blood cell and platelet components, which are essential for oxygen transport and blood clotting, respectively.

The artificial blood was tested on 10 rabbits suffering from severe blood loss. Six of them survived after receiving the synthetic transfusion—results that matched or exceeded the survival rate seen in traditional transfusions.

Why Universal Blood Is a Game-Changer

1. Solving the Global Blood Shortage

Every year, millions of people die due to the lack of timely access to compatible blood. According to the WHO, low- and middle-income countries face chronic blood shortages, and matching blood types further limits access.

https://www.globelisted.com/universal-artificial-blood-developed-in-japan/

2. Ideal for Natural Disasters and War Zones

In high-pressure scenarios—like natural disasters, military conflicts, or accidents—time is critical. There's often no time to type-match blood or locate rare donors. Artificial blood, especially in portable bags with long shelf lives, offers an immediate solution in such emergencies.

3. Lower Risk of Contamination or Rejection

Donor blood comes with risks: infections (like HIV, Hepatitis), allergic reactions, and immune responses. Since artificial blood is lab-synthesized, the risks of contamination and rejection are significantly reduced.

4. Supporting Rural and Remote Healthcare

One of the biggest limitations of blood transfusions in rural areas is lack of storage infrastructure and inconsistent donor availability. Artificial blood, being more durable and easier to store, could bridge that healthcare gap.

Essentially, Japan's innovation could democratize access to lifesaving care on a global scale.

For more blogs, visit: https://www.globelisted.com/